Points to consider in the development of seed stocks of
pluripotent stem cells for clinical applications: International
Stem Cell Banking Initiative (ISCBI)

J 2015

Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)

ANDREWS, P.W., D. BAKER, N. BENVINISTY, B. MIRANDA, K. BRUCE et. al.

Základní údaje

Originální název

Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)

Autoři

ANDREWS, P.W. (826 Velká Británie a Severní Irsko), D. BAKER (826 Velká Británie a Severní Irsko), N. BENVINISTY (376 Izrael), B. MIRANDA (724 Španělsko), K. BRUCE (826 Velká Británie a Severní Irsko), O. BRUSTLE (276 Německo), M. CHOI (410 Korejská republika), Y.M. CHOI (410 Korejská republika), J.M. CROOK (36 Austrálie), P.A. de SOUSA (826 Velká Británie a Severní Irsko), Petr DVOŘÁK (203 Česká republika, garant, domácí), C. FREUND (528 Nizozemské království), M. FIRPO (840 Spojené státy), M.K. FURUE (392 Japonsko), P. GOKHALE (826 Velká Británie a Severní Irsko), H.Y. HA (410 Korejská republika), E. HAN (410 Korejská republika), S. HAUPT (276 Německo), L. HEALY (826 Velká Británie a Severní Irsko), D.J. HEI (840 Spojené státy), O. HOVATTA (752 Švédsko), C. HUNT (826 Velká Británie a Severní Irsko), S.M. HWANG (158 Tchaj-wan), M.S. INAMDAR (356 Indie), R.M. ISASI (124 Kanada), M. JACONI (756 Švýcarsko), V. JEKERLE (826 Velká Británie a Severní Irsko), P. KAMTHORN (764 Thajsko), M.C. KIBBEY (840 Spojené státy), I. KNEZEVIC (756 Švýcarsko), B.B. KNOWLES (764 Thajsko), S.K. KOO (410 Korejská republika), Y. LAABI (250 Francie), L. LEOPOLDO (724 Španělsko), P. LIU (826 Velká Británie a Severní Irsko), G.P. LOMAX (840 Spojené státy), J.F. LORING (840 Spojené státy), T.E. LUDWIG (840 Spojené státy), K. MONTGOMERY (840 Spojené státy), C. MUMMERY (528 Nizozemské království), A. NAGY (124 Kanada), Y. NAKAMURA (392 Japonsko), N. NAKATSUJI (392 Japonsko), S. OH (702 Singapur), S.K. OH (410 Korejská republika), T. OTONKOSKI (246 Finsko), M. PERA (840 Spojené státy), M. PESCHANSKI (250 Francie), P. PRANKE (76 Brazílie), K.M. RAJALA (246 Finsko), M. RAO (840 Spojené státy), R. RUTTACHUK (764 Thajsko), B. REUBINOFF (376 Izrael), L. RICCO (724 Španělsko), H. ROOKE (840 Spojené státy), D. SIPP (840 Spojené státy), G.N. STACEY (826 Velká Británie a Severní Irsko), H. SUEMORI (392 Japonsko), T.A. TAKAHASHI (392 Japonsko), K. TAKADA (392 Japonsko), S. TALIB (840 Spojené státy), S. TANNENBAUM (376 Izrael), B.Z. YUAN (156 Čína), F. ZENG (156 Čína) a Q. ZHOU (156 Čína)

Vydání

REGENERATIVE MEDICINE, LONDON, FUTURE MEDICINE LTD, 2015, 1746-0751

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

Genetika a molekulární biologie

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.602

Kód RIV

RIV/00216224:14110/15:00083494

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.2217/RME.14.93

UT WoS

000349681900001

Klíčová slova anglicky

COPY NUMBER; MOLECULAR CYTOGENETICS; GENOMIC STABILITY; GENE-EXPRESSION; LINES; CULTURE; CRYOPRESERVATION; MUTATIONS; TERATOCARCINOMAS; STANDARDIZATION

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 3. 8. 2015 10:06, Soňa Böhmová

Anotace

V originále

In 2009 the International Stem Cell Banking Initiative (ISCBI) contributors and the Ethics Working Party of the International Stem Cell Forum published a consensus on principles of best practice for the procurement, cell banking, testing and distribution of human embryonic stem cell (hESC) lines for research purposes [1], which was broadly also applicable to human induced pluripotent stem cell (hiPSC) lines. Here, we revisit this guidance to consider what the requirements would be for delivery of the early seed stocks of stem cell lines intended for clinical applications. The term ‘seed stock’ is used here to describe those cryopreserved stocks of cells established early in the passage history of a pluripotent stem cell line in the lab that derived the line or a stem cell bank, hereafter called the ‘repository’.

Citovat

ANDREWS, P.W., D. BAKER, N. BENVINISTY, B. MIRANDA, K. BRUCE, O. BRUSTLE, M. CHOI, Y.M. CHOI, J.M. CROOK, P.A. de SOUSA, Petr DVOŘÁK, C. FREUND, M. FIRPO, M.K. FURUE, P. GOKHALE, H.Y. HA, E. HAN, S. HAUPT, L. HEALY, D.J. HEI, O. HOVATTA, C. HUNT, S.M. HWANG, M.S. INAMDAR, R.M. ISASI, M. JACONI, V. JEKERLE, P. KAMTHORN, M.C. KIBBEY, I. KNEZEVIC, B.B. KNOWLES, S.K. KOO, Y. LAABI, L. LEOPOLDO, P. LIU, G.P. LOMAX, J.F. LORING, T.E. LUDWIG, K. MONTGOMERY, C. MUMMERY, A. NAGY, Y. NAKAMURA, N. NAKATSUJI, S. OH, S.K. OH, T. OTONKOSKI, M. PERA, M. PESCHANSKI, P. PRANKE, K.M. RAJALA, M. RAO, R. RUTTACHUK, B. REUBINOFF, L. RICCO, H. ROOKE, D. SIPP, G.N. STACEY, H. SUEMORI, T.A. TAKAHASHI, K. TAKADA, S. TALIB, S. TANNENBAUM, B.Z. YUAN, F. ZENG a Q. ZHOU. Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). REGENERATIVE MEDICINE. LONDON: FUTURE MEDICINE LTD, 2015, roč. 10, č. 2, s. 1-44. ISSN 1746-0751. Dostupné z: https://dx.doi.org/10.2217/RME.14.93.

@article{1307860,
   author = {Andrews, P.W. and Baker, D. and Benvinisty, N. and Miranda, B. and Bruce, K. and Brustle, O. and Choi, M. and Choi, Y.M. and Crook, J.M. and Sousa, P.A. de and Dvořák, Petr and Freund, C. and Firpo, M. and Furue, M.K. and Gokhale, P. and Ha, H.Y. and Han, E. and Haupt, S. and Healy, L. and Hei, D.J. and Hovatta, O. and Hunt, C. and Hwang, S.M. and Inamdar, M.S. and Isasi, R.M. and Jaconi, M. and Jekerle, V. and Kamthorn, P. and Kibbey, M.C. and Knezevic, I. and Knowles, B.B. and Koo, S.K. and Laabi, Y. and Leopoldo, L. and Liu, P. and Lomax, G.P. and Loring, J.F. and Ludwig, T.E. and Montgomery, K. and Mummery, C. and Nagy, A. and Nakamura, Y. and Nakatsuji, N. and Oh, S. and Oh, S.K. and Otonkoski, T. and Pera, M. and Peschanski, M. and Pranke, P. and Rajala, K.M. and Rao, M. and Ruttachuk, R. and Reubinoff, B. and Ricco, L. and Rooke, H. and Sipp, D. and Stacey, G.N. and Suemori, H. and Takahashi, T.A. and Takada, K. and Talib, S. and Tannenbaum, S. and Yuan, B.Z. and Zeng, F. and Zhou, Q.},
   article_location = {LONDON},
   article_number = {2},
   doi = {http://dx.doi.org/10.2217/RME.14.93},
   keywords = {COPY NUMBER; MOLECULAR CYTOGENETICS; GENOMIC STABILITY; GENE-EXPRESSION; LINES; CULTURE; CRYOPRESERVATION; MUTATIONS; TERATOCARCINOMAS; STANDARDIZATION},
   language = {eng},
   issn = {1746-0751},
   journal = {REGENERATIVE MEDICINE},
   title = {Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)},
   volume = {10},
   year = {2015}
}

TY  - JOUR
ID  - 1307860
AU  - Andrews, P.W. - Baker, D. - Benvinisty, N. - Miranda, B. - Bruce, K. - Brustle, O. - Choi, M. - Choi, Y.M. - Crook, J.M. - Sousa, P.A. de - Dvořák, Petr - Freund, C. - Firpo, M. - Furue, M.K. - Gokhale, P. - Ha, H.Y. - Han, E. - Haupt, S. - Healy, L. - Hei, D.J. - Hovatta, O. - Hunt, C. - Hwang, S.M. - Inamdar, M.S. - Isasi, R.M. - Jaconi, M. - Jekerle, V. - Kamthorn, P. - Kibbey, M.C. - Knezevic, I. - Knowles, B.B. - Koo, S.K. - Laabi, Y. - Leopoldo, L. - Liu, P. - Lomax, G.P. - Loring, J.F. - Ludwig, T.E. - Montgomery, K. - Mummery, C. - Nagy, A. - Nakamura, Y. - Nakatsuji, N. - Oh, S. - Oh, S.K. - Otonkoski, T. - Pera, M. - Peschanski, M. - Pranke, P. - Rajala, K.M. - Rao, M. - Ruttachuk, R. - Reubinoff, B. - Ricco, L. - Rooke, H. - Sipp, D. - Stacey, G.N. - Suemori, H. - Takahashi, T.A. - Takada, K. - Talib, S. - Tannenbaum, S. - Yuan, B.Z. - Zeng, F. - Zhou, Q.
PY  - 2015
TI  - Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)
JF  - REGENERATIVE MEDICINE
VL  - 10
IS  - 2
SP  - 1-44
EP  - 1-44
PB  - FUTURE MEDICINE LTD
SN  - 17460751
KW  - COPY NUMBER
KW  - MOLECULAR CYTOGENETICS
KW  - GENOMIC STABILITY
KW  - GENE-EXPRESSION
KW  - LINES
KW  - CULTURE
KW  - CRYOPRESERVATION
KW  - MUTATIONS
KW  - TERATOCARCINOMAS
KW  - STANDARDIZATION
N2  - In 2009 the International Stem Cell Banking Initiative (ISCBI) contributors and the Ethics Working Party of the International Stem Cell Forum published a consensus on principles of best practice for the procurement, cell banking, testing and distribution of human embryonic stem cell (hESC) lines for research purposes [1], which was broadly also applicable to human induced pluripotent stem cell (hiPSC) lines. Here, we revisit this guidance to consider what the requirements would be for delivery of the early seed stocks of stem cell lines intended for clinical applications. The term ‘seed stock’ is used here to describe those cryopreserved stocks of cells established early in the passage history of a pluripotent stem cell line in the lab that derived the line or a stem cell bank, hereafter called the ‘repository’.
ER  -

ANDREWS, P.W., D. BAKER, N. BENVINISTY, B. MIRANDA, K. BRUCE, O. BRUSTLE, M. CHOI, Y.M. CHOI, J.M. CROOK, P.A. de SOUSA, Petr DVOŘÁK, C. FREUND, M. FIRPO, M.K. FURUE, P. GOKHALE, H.Y. HA, E. HAN, S. HAUPT, L. HEALY, D.J. HEI, O. HOVATTA, C. HUNT, S.M. HWANG, M.S. INAMDAR, R.M. ISASI, M. JACONI, V. JEKERLE, P. KAMTHORN, M.C. KIBBEY, I. KNEZEVIC, B.B. KNOWLES, S.K. KOO, Y. LAABI, L. LEOPOLDO, P. LIU, G.P. LOMAX, J.F. LORING, T.E. LUDWIG, K. MONTGOMERY, C. MUMMERY, A. NAGY, Y. NAKAMURA, N. NAKATSUJI, S. OH, S.K. OH, T. OTONKOSKI, M. PERA, M. PESCHANSKI, P. PRANKE, K.M. RAJALA, M. RAO, R. RUTTACHUK, B. REUBINOFF, L. RICCO, H. ROOKE, D. SIPP, G.N. STACEY, H. SUEMORI, T.A. TAKAHASHI, K. TAKADA, S. TALIB, S. TANNENBAUM, B.Z. YUAN, F. ZENG a Q. ZHOU. Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). \textit{REGENERATIVE MEDICINE}. LONDON: FUTURE MEDICINE LTD, 2015, roč.~10, č.~2, s.~1-44. ISSN~1746-0751. Dostupné z: https://dx.doi.org/10.2217/RME.14.93.

Podrobný výpis o publikaci